162 related articles for article (PubMed ID: 11268394)
1. SOCS proteins: modulators of neuroimmunoendocrine functions. Impact on corticotroph LIF signaling.
Auernhammer CJ; Bousquet C; Chesnokova V; Melmed S
Ann N Y Acad Sci; 2000; 917():658-64. PubMed ID: 11268394
[TBL] [Abstract][Full Text] [Related]
2. Pituitary corticotroph SOCS-3: novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion.
Auernhammer CJ; Chesnokova V; Bousquet C; Melmed S
Mol Endocrinol; 1998 Jul; 12(7):954-61. PubMed ID: 9658400
[TBL] [Abstract][Full Text] [Related]
3. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction.
Nicholson SE; Willson TA; Farley A; Starr R; Zhang JG; Baca M; Alexander WS; Metcalf D; Hilton DJ; Nicola NA
EMBO J; 1999 Jan; 18(2):375-85. PubMed ID: 9889194
[TBL] [Abstract][Full Text] [Related]
4. cAMP neuropeptide agonists induce pituitary suppressor of cytokine signaling-3: novel negative feedback mechanism for corticotroph cytokine action.
Bousquet C; Chesnokova V; Kariagina A; Ferrand A; Melmed S
Mol Endocrinol; 2001 Nov; 15(11):1880-90. PubMed ID: 11682619
[TBL] [Abstract][Full Text] [Related]
5. Novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) stimulates corticotroph function via a signal transducer and activator of transcription-dependent mechanism negatively regulated by suppressor of cytokine signaling-3.
Auernhammer CJ; Isele NB; Kopp FB; Spoettl G; Cengic N; Weber MM; Senaldi G; Engelhardt D
Endocrinology; 2003 Apr; 144(4):1202-10. PubMed ID: 12639901
[TBL] [Abstract][Full Text] [Related]
6. Opposing effects of pituitary leukemia inhibitory factor and SOCS-3 on the ACTH axis response to inflammation.
Chesnokova V; Kariagina A; Melmed S
Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1110-8. PubMed ID: 11934677
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
Bousquet C; Susini C; Melmed S
J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
[TBL] [Abstract][Full Text] [Related]
8. Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter.
Auernhammer CJ; Bousquet C; Melmed S
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6964-9. PubMed ID: 10359822
[TBL] [Abstract][Full Text] [Related]
9. Suppressors of cytokine signalling: SOCS.
Larsen L; Röpke C
APMIS; 2002 Dec; 110(12):833-44. PubMed ID: 12645661
[TBL] [Abstract][Full Text] [Related]
10. Independent roles of SOCS-3 and SHP-2 in the regulation of neuronal gene expression by leukemia inhibitory factor.
Bartoe JL; Nathanson NM
Brain Res Mol Brain Res; 2002 Nov; 107(2):108-19. PubMed ID: 12425940
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of gp130 cytokine effects on corticotroph AtT-20 cells--redundancy or specificity of neuroimmunoendocrine modulators?
Auernhammer CJ; Kopp FB; Vlotides G; Dorn F; Isele NB; Spöttl G; Cengic N; Weber MM; Senaldi G; Engelhardt D
Neuroimmunomodulation; 2004; 11(4):224-32. PubMed ID: 15249728
[TBL] [Abstract][Full Text] [Related]
12. Role of suppressors of cytokine signaling (Socs) in leukemia inhibitory factor (LIF) -dependent embryonic stem cell survival.
Duval D; Reinhardt B; Kedinger C; Boeuf H
FASEB J; 2000 Aug; 14(11):1577-84. PubMed ID: 10928992
[TBL] [Abstract][Full Text] [Related]
13. Cytokine signaling in the brain: putting a SOCS in it?
Wang J; Campbell IL
J Neurosci Res; 2002 Feb; 67(4):423-7. PubMed ID: 11835308
[TBL] [Abstract][Full Text] [Related]
14. A family of cytokine-inducible inhibitors of signalling.
Starr R; Willson TA; Viney EM; Murray LJ; Rayner JR; Jenkins BJ; Gonda TJ; Alexander WS; Metcalf D; Nicola NA; Hilton DJ
Nature; 1997 Jun; 387(6636):917-21. PubMed ID: 9202125
[TBL] [Abstract][Full Text] [Related]
15. Suppressors of cytokine signaling: Relevance to gastrointestinal function and disease.
Greenhalgh CJ; Miller ME; Hilton DJ; Lund PK
Gastroenterology; 2002 Dec; 123(6):2064-81. PubMed ID: 12454862
[TBL] [Abstract][Full Text] [Related]
16. Leukemia inhibitory factor mediates the hypothalamic pituitary adrenal axis response to inflammation.
Chesnokova V; Melmed S
Endocrinology; 2000 Nov; 141(11):4032-40. PubMed ID: 11089533
[TBL] [Abstract][Full Text] [Related]
17. Suppressors of cytokine signalling (SOCS): putative modulators of cytokine bioactivity in health and disease.
Diamond P; Doran P; Brady HR; McGinty A
J Nephrol; 2000; 13(1):9-14. PubMed ID: 10720209
[TBL] [Abstract][Full Text] [Related]
18. LIF-induced STAT3 signaling in murine versus human embryonal carcinoma (EC) cells.
Schuringa JJ; van der Schaaf S; Vellenga E; Eggen BJ; Kruijer W
Exp Cell Res; 2002 Mar; 274(1):119-29. PubMed ID: 11855863
[TBL] [Abstract][Full Text] [Related]
19. Cell-specific pituitary gene expression profiles after treatment with leukemia inhibitory factor reveal novel modulators for proopiomelanocortin expression.
Abbud RA; Kelleher R; Melmed S
Endocrinology; 2004 Feb; 145(2):867-80. PubMed ID: 14576184
[TBL] [Abstract][Full Text] [Related]
20. CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT3 activation in M1 leukemia cells.
Suzuki R; Sakamoto H; Yasukawa H; Masuhara M; Wakioka T; Sasaki A; Yuge K; Komiya S; Inoue A; Yoshimura A
Oncogene; 1998 Oct; 17(17):2271-8. PubMed ID: 9811457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
